Cargando…
Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study
BACKGROUND: The liver is the most common site for rectal cancer metastasis, and liver resection combined with chemotherapy is the only treatment offering the possibility of long-term survival in patients with metastatic rectal cancer. However, a significant proportion of liver metastases cannot be s...
Autores principales: | Chen, Jianan, Chen, Haipeng, Zhao, Fuqiang, Wang, Zheng, Liu, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841683/ https://www.ncbi.nlm.nih.gov/pubmed/35261894 http://dx.doi.org/10.21037/tcr-21-1399 |
Ejemplares similares
-
Adjuvant chemoradiotherapy in resected gallbladder cancer: A SEER-based study
por: Jiang, Yong, et al.
Publicado: (2023) -
Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
por: Song, Jianyuan, et al.
Publicado: (2020) -
Primary Tumor Resection for Rectal Cancer With Unresectable Liver Metastases: A Chance to Cut Is a Chance for Improved Survival
por: Chen, Jia-nan, et al.
Publicado: (2021) -
Impact of Adjuvant Chemoradiotherapy on Survival of Resected Pancreatic Adenocarcinoma Cancer: A Surveillance, Epidemiology and End Results (SEER) Analysis
por: Shi, Xiaomao, et al.
Publicado: (2021) -
The Influence of the Distal Resection Margin Length on Local Recurrence and long- term Survival in Patients with Rectal Cancer after Chemoradiotherapy and Sphincter- Preserving Rectal Resection
por: Grosek, Jan, et al.
Publicado: (2016)